Zoetis beats profit estimates on strong demand for pet products
- Animal healthcare company Zoetis surpassed analysts' expectations for first-quarter profit on Thursday, helped by strong demand for its medicines and vaccines for pets.
- 05/02/2024
|
Zoetis Reports Earnings Thursday. The Company Must Address Dog Pain Drug Safety Worries.
- The animal health firm has had a tough year with shares down nearly 20% amid negative media reports about a key new medicine.
- 05/01/2024
|
Furry Tech Boom: 3 Pet Stocks Unleashing the Power of AI
- Fortune.com recently reported that artificial intelligence (AI) is helping the pet care industry cope with a chronic veterinary shortage. AI use cases could become far more prevalent for pets than humans in the near term due to fewer impediments such as privacy laws.
- 05/01/2024
|
Unveiling Zoetis (ZTS) Q1 Outlook: Wall Street Estimates for Key Metrics
- Besides Wall Street's top -and-bottom-line estimates for Zoetis (ZTS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
- 04/29/2024
|
Wall Street Analysts Look Bullish on Zoetis (ZTS): Should You Buy?
- The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
- 04/26/2024
|
Zoetis (ZTS) Stock Dips While Market Gains: Key Facts
- In the latest trading session, Zoetis (ZTS) closed at $145.54, marking a -0.66% move from the previous day.
- 04/22/2024
|
Suddenly, There's An Alternative - The Important Case For Wide Moat Dividend Stocks
- Short-term bonds currently yield more than stocks, indicating a shift in the investment environment. Investors should focus on companies with healthy balance sheets, pricing power, and that are trading below their fair value. We suggest several favorite wide-moat dividend businesses.
- 04/18/2024
|
Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment
- Zoetis Inc. has seen a significant decline in its stock price, dropping more than 24% since January. The decline is partly due to market weakness and the ongoing growth to value rotation, as well as headlines about the potential adverse effects of one of its key drugs. Despite the setbacks, Zoetis' core business remains strong, with robust top-line and bottom-line growth expectations, diversified growth opportunities, and a stable dividend.
- 04/14/2024
|
Zoetis shares drop amid concerns over arthritis shots' safety for pets
- Zoetis Inc (NYSE:ZTS, ETR:ZOE) shares took a hit Friday after a Wall Street Journal report that suggested the company's arthritis shots may have sickened dogs and cats. The arthritis shots, Librela and Solensia, target osteoarthritis by focusing on nerve growth factor protein.
- 04/12/2024
|
Zoetis Stock Falls on Concerns Over Pet Arthritis Drugs. Company Says They're Safe.
- An article in The Wall Street Journal highlights the scrutiny over the company's arthritis treatments for pets.
- 04/12/2024
|
Zoetis's stock falls 7% to lead S&P 500 decliners after report its arthritis shots have sickened pets
- Zoetis Inc.'s stock ZTS, -7.77% tumbled 7% Friday to lead S&P 500 decliners, after a Wall Street Journal report that the company's arthritis shots Librela and Solensia may have sickened pet cats and dogs. The two shots won Food and Drug Administration approval in 2022 and 2023 as the first antibody drugs for pets.
- 04/12/2024
|
Why Zoetis (ZTS) Dipped More Than Broader Market Today
- The latest trading day saw Zoetis (ZTS) settling at $165.69, representing a -0.1% change from its previous close.
- 04/08/2024
|
My Top 15 High Growth Dividend Stocks For April 2024
- The SPDR S&P 500 ETF Trust had a 3.27% return in March, outperforming Vanguard's Dividend Appreciation Index Fund ETF Shares. The top 15 dividend growth stocks for April 2024 offer an average dividend yield of 1.44% and appear to be about 24% undervalued based on dividend yield theory.
- 04/01/2024
|
Is It Time to Buy the S&P 500's 3 Worst-Performing Stocks of March?
- Lululemon offered weaker-than-expected guidance in its fourth-quarter earnings report. Southwest cut its guidance in response to the crisis at Boeing.
- 04/01/2024
|
Zoetis to Host Webcast and Conference Call on First Quarter 2024 Financial Results
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 2, 2024. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review first quarter 2024 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-presentation.
- 03/28/2024
|
You Don't Have To Take Excess Risk To Beat The Market
- It is possible for retail investors to consistently beat the market by owning above-average blue chip dividend growth stocks. Hard work, research, and staying rational are key factors in outperforming the market. I highlight specific blue chip stocks, such as Booking Holdings, Zoetis, UnitedHealth Group, and Elevance Health, that have strong growth potential and attractive valuations.
- 03/25/2024
|
Zoetis: My Favorite Healthcare Stock Right Now
- Zoetis Inc. has shown unique compounding results since spinning off from Pfizer, with double-digit EPS and dividend growth CAGRs since inception. The loneliness epidemic is driving demand for companion animals, and Zoetis is well positioned to benefit from the rise in pet ownership and pet-related spending. Zoetis has a strong position in the animal health market, with increased pricing power and limited competition, making it a best-in-class asset in the industry.
- 03/21/2024
|
My Top 15 High Growth Dividend Stocks For March 2024
- The SPDR S&P 500 ETF Trust had a 5.22% return in February, outperforming Vanguard's Dividend Appreciation Index Fund ETF Shares.
- 03/03/2024
|
Zoetis: Buy This High-Quality Dividend Growth Beast On Weakness
- Zoetis: Buy This High-Quality Dividend Growth Beast On Weakness
- 02/27/2024
|
1 Magnificent S&P 500 Dividend Stock Down 23% to Buy Right Now
- Zoetis is the world's largest producer of medicine and vaccinations for pets and livestock. It's also been incredibly profitable for its shareholders since its spinoff from Pfizer.
- 02/26/2024
|
5 Dividend Growth Stocks That Outperformed S&P 500 Over 5-Year Rolling Periods
- Beating the S&P 500 is difficult due to skewed market returns favoring a few high-performing stocks.
- 02/19/2024
|
GRFS or ZTS: Which Is the Better Value Stock Right Now?
- Investors with an interest in Medical - Drugs stocks have likely encountered both Grifols (GRFS) and Zoetis (ZTS). But which of these two stocks offers value investors a better bang for their buck right now?
- 02/14/2024
|
Zoetis CEO Kristin Peck on Q4 earnings
- Kristin Peck, Zoetis CEO, joins 'Money Movers' to discuss what Zoetis' guidance says about Peck's business expectations, factors that are contributing to their growth relative to fundamentals, and how consumers are thinking about their pets.
- 02/13/2024
|
Zoetis' (ZTS) Q4 Earnings Miss Expectations, Sales Beat
- Zoetis (ZTS) reports mixed fourth-quarter results, wherein earnings miss estimates while revenues beat the same.
- 02/13/2024
|
Compared to Estimates, Zoetis (ZTS) Q4 Earnings: A Look at Key Metrics
- The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 02/13/2024
|
Zoetis (ZTS) Q4 Earnings Lag Estimates
- Zoetis (ZTS) came out with quarterly earnings of $1.24 per share, missing the Zacks Consensus Estimate of $1.33 per share. This compares to earnings of $1.15 per share a year ago.
- 02/13/2024
|
Ahead of Zoetis (ZTS) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
- Beyond analysts' top -and-bottom-line estimates for Zoetis (ZTS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
- 02/08/2024
|
Daily Dividend Report: Mastercard, MMM, Gilead, Keurig, Zoetis
- Mastercard today announced that its Board of Directors has declared a quarterly cash dividend of 66 cents per share. The cash dividend will be paid on May 9, 2024 to holders of record of its Class A common stock and Class B common stock as of April 9, 2024.
- 02/07/2024
|
Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth
- Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 02/06/2024
|
GRFS or ZTS: Which Is the Better Value Stock Right Now?
- Investors interested in stocks from the Medical - Drugs sector have probably already heard of Grifols (GRFS) and Zoetis (ZTS). But which of these two stocks presents investors with the better value opportunity right now?
- 01/29/2024
|
4 Magnificent Stocks I'm Done Waiting on a Dip for in 2024 -- but I'm Not Buying Them Hand Over Fist, Either
- Celsius brings triple-digit sales growth with newfound profitability. Cintas and Rollins are home to products you don't know you love until you don't have them.
- 01/20/2024
|
Will Zoetis (ZTS) Beat Estimates Again in Its Next Earnings Report?
- Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/15/2024
|
GRFS vs. ZTS: Which Stock Is the Better Value Option?
- Investors looking for stocks in the Medical - Drugs sector might want to consider either Grifols (GRFS) or Zoetis (ZTS). But which of these two stocks presents investors with the better value opportunity right now?
- 01/12/2024
|
Zoetis CFO on animal health trends and using AI for medicine
- Zoetis CFO Wetteny Joseph discusses growth in the animal health care sector.
- 01/12/2024
|
5 Upcoming Dividend Increases
- 5 Upcoming Dividend Increases
- 01/12/2024
|
Here are Wall Street's favorite stocks in the sector expected to grow profits the most in 2024
- Each earnings reporting season, you can count on a flurry of articles with headlines saying companies “beat” consensus estimates for quarterly profits. But that “success” alone means nothing.
- 01/09/2024
|
My Top 15 High Growth Dividend Stocks For January 2024
- The SPDR S&P 500 ETF was up 4.57% in December, Vanguard's Dividend Appreciation ETF was up 4.13%, and my watchlist beat both with a return of 9.52%.
- 01/02/2024
|
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2023 Financial Results
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Feb. 13, 2024. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review fourth quarter and full year 2023 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/eve.
- 12/28/2023
|
GRFS or ZTS: Which Is the Better Value Stock Right Now?
- Investors looking for stocks in the Medical - Drugs sector might want to consider either Grifols (GRFS) or Zoetis (ZTS). But which of these two companies is the best option for those looking for undervalued stocks?
- 12/27/2023
|
Pet Care Profits: 3 Stocks Benefitting from the Pet Boom
- Pet care stocks are incredibly effective in diversifying investment portfolios, leveraging the robust growth of the pet care industry. The sector's expansion is evident.
- 12/26/2023
|
Forever Favorites: 7 Dividend Stocks to Buy and Never Sell
- Some investments just look after themselves. They are “set it and forget it” kind of stocks.
- 12/19/2023
|
Our Top 10 Dividend Growth Stocks - December 2023
- We focus on selecting high-growth dividend stocks that have rapidly grown their dividends in the recent past rather than a high current yield. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. We provide criteria for selecting high-growth dividend stocks and offer a step-by-step guide on structuring a portfolio based on this strategy.
- 12/16/2023
|
4 Stocks to Watch That Recently Declared Dividend Hikes
- Invitation Homes Inc. (INVH), Choice Hotels International, Inc. (CHH), Zoetis Inc. (ZTS) and Owens Corning (OC) recently announced dividend hikes.
- 12/11/2023
|
3 Promising Stocks to Buy in the Booming Pet Tech Industry
- Pet stocks are an exciting way to diversify your portfolio. These companies ride high on the tailwinds of the pet care industry, which took many analysts by surprise.
- 12/07/2023
|
My Top 15 High Growth Dividend Stocks For December 2023
- The SPDR S&P 500 ETF was up 9.13% in November, Vanguard's Dividend Appreciation ETF was up 7.47%, my watchlist beat both with a return of 10.24%. The top 15 dividend growth stocks for December offer an average dividend yield of 1.99% and appear to be about 34% undervalued based on dividend yield theory. Since inception, September 2020, the watchlist is rocking a cool 11.76% annualized return, beating VIG by 2.36% and SPY by 1.52%.
- 12/03/2023
|
3 Pet Care Stocks to Capitalize on the Animal Economy
- Most recent data shows that 66% of U.S. households own a pet. Another interesting point is that “85% of dog owners and 76% of cat owners consider their pets to be a member of the family.
- 11/22/2023
|
My Top 15 High Growth Dividend Stocks For November 2023
- The SPDR S&P 500 ETF posted its third consecutive losing month in October, the first time this has happened since I started tracking this series in September 2020. The top 15 dividend growth stocks for November offer an average dividend yield of 1.90% and appear to be about 40% undervalued based on dividend yield theory. Since inception, September 2020, the watchlist is outperforming VIG by 1.49% and SPY by 1.18%, on an annualized basis.
- 11/03/2023
|
Here's What Key Metrics Tell Us About Zoetis (ZTS) Q3 Earnings
- While the top- and bottom-line numbers for Zoetis (ZTS) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 11/02/2023
|
Zoetis CEO on Q3 earnings: We keep seeing the resilience of the animal health sector amid downturns
- Kristin Peck, Zoetis CEO, joins 'Squawk on the Street' to discuss her insights into livestock and pet care products, how tied Zoetis' business is to the macro economy, and more.
- 11/02/2023
|
JAZZ vs. ZTS: Which Stock Is the Better Value Option?
- Investors with an interest in Medical - Drugs stocks have likely encountered both Jazz Pharmaceuticals (JAZZ) and Zoetis (ZTS). But which of these two stocks is more attractive to value investors?
- 10/26/2023
|
Zoetis: Significant CapEx Investments For Long-Term Growth, But A Hold Now
- Zoetis is an animal health company specializing in the development and manufacturing of veterinary pharmaceuticals and vaccines for both livestock and companion animals. For FY2023, the company has announced a $1 billion investment to enhance manufacturing capacity for monoclonal antibodies. This is the largest investment in its history. The company is sacrificing the short term to benefit in the long term. Which seems like a great decision and demonstrates an amazing corporate culture.
- 10/26/2023
|
Our Top 10 Picks For Dividend Growth Stocks - October 2023
- We pick high-growth dividend stocks that have rapidly grown their dividends in the recent past rather than offering a high current yield. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. We provide criteria for selecting high-growth dividend stocks, offering a step-by-step guide on structuring a portfolio based on this strategy.
- 10/21/2023
|
The Top 7 Stocks to Own During a Downturn
- As uncertainty seems to dominate, it might be time to look for stocks to own during a downturn. For 10 straight months, investors enjoyed a strong comeback rally in the S&P 500.
- 10/11/2023
|
JAZZ or ZTS: Which Is the Better Value Stock Right Now?
- Investors looking for stocks in the Medical - Drugs sector might want to consider either Jazz Pharmaceuticals (JAZZ) or Zoetis (ZTS). But which of these two stocks presents investors with the better value opportunity right now?
- 10/10/2023
|
Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again
- Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 10/06/2023
|
Which Is A Better Pick – Keurig Dr Pepper Stock Or Zoetis?
- We believe that Zoetis stock (NYSE: ZTS), an animal health company, is a better pick than Keurig Dr Pepper stock (NASDAQ: KDP), given its better prospects.
- 09/27/2023
|
Zoetis Is An Impressive Healthcare Compounder
- Zoetis Inc., the world's largest provider of animal medicines, vaccines, and diagnostic products, is capitalizing on the growing trend of pet pampering. The company dominates the companion animal and cattle markets, which are anti-cyclical and have strong growth potential. Zoetis expects to sustain above-average growth through innovation, strategic investments, and leveraging its broad product portfolio.
- 09/26/2023
|
Our Top 10 Picks For Dividend Growth Stocks - September 2023
- This monthly series of articles focuses on DGI stocks likely to provide a high rate of dividend growth rather than a high current yield. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. The article provides criteria for selecting high-growth dividend stocks. It offers a step-by-step guide on structuring a portfolio based on this strategy.
- 09/17/2023
|
USNA vs. ZTS: Which Stock Is the Better Value Option?
- Investors interested in Medical - Drugs stocks are likely familiar with USANA Health Sciences (USNA) and Zoetis (ZTS). But which of these two companies is the best option for those looking for undervalued stocks?
- 09/13/2023
|
Zoetis to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #Fortune500--Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 21st Annual Global Healthcare Conference on Tuesday, Sept. 12, 2023. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 12:55 p.m. ET. Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-pr.
- 09/06/2023
|
My Top 15 High Growth Dividend Stocks For September 2023
- The summer stock market rally ended in August, with the SPDR S&P 500 Trust ETF posting a loss of 1.63%. The top 15 dividend growth stocks for September offer an average dividend yield of 1.86% and appear about 36% undervalued based on dividend yield theory. Since inception, September 2020, the watchlist is beating VIG by 3.91% and SPY by 3.12%.
- 09/04/2023
|
USNA vs. ZTS: Which Stock Should Value Investors Buy Now?
- Investors with an interest in Medical - Drugs stocks have likely encountered both USANA Health Sciences (USNA) and Zoetis (ZTS). But which of these two companies is the best option for those looking for undervalued stocks?
- 08/28/2023
|
Zoetis' (ZTS) Companion Animal Products to Boost Revenues
- Zoetis' (ZTS) revenues are expected to boost the pet care and livestock product sales in the quarters ahead. Disease outbreaks and potential supply challenges hurt prospects.
- 08/23/2023
|
Our Top 10 Picks For Dividend Growth Stocks - August 2023
- This monthly series of articles focuses on DGI stocks that are likely to provide a high rate of dividend growth rather than a high current yield. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. The article provides criteria for selecting high-growth dividend stocks and offers a step-by-step guide on how to structure a portfolio based on this strategy.
- 08/19/2023
|
USNA or ZTS: Which Is the Better Value Stock Right Now?
- Investors interested in stocks from the Medical - Drugs sector have probably already heard of USANA Health Sciences (USNA) and Zoetis (ZTS). But which of these two stocks is more attractive to value investors?
- 08/10/2023
|
Zoetis CEO Kristin Peck on Q2 earnings results, state of animal health care
- Kristin Peck, Zoetis CEO, joins 'Squawk on the Street' to discuss what the company's guidance was largely driven by, the most important aspect of Zoetis' business, and how new GLP-1 drugs could play into Zoetis' business.
- 08/08/2023
|
Zoetis Inc. (ZTS) Q22023 Earnings Call Transcript
- Zoetis Inc. (NYSE:ZTS ) Q22023 Earnings Conference Call August 8, 2023 8:30 AM ET Company Participants Steve Frank - Vice President of Investor Relations Kristin Peck - Chief Executive Officer Wetteny Joseph - Chief Financial Officer Conference Call Participants Michael Ryskin - Bank of America Nathan Rich - Goldman Sachs Jon Block - Stifel David Westenberg - Piper Sandler Brandon Vazquez - William Blair Louise Chen - Cantor Operator Welcome to the Second Quarter 2023 Financial Results Conference Call and Webcast for Zoetis. Hosting the call today is Steve Frank, Vice President of Investor Relations for Zoetis.
- 08/08/2023
|
Zoetis (ZTS) Reports Q2 Earnings: What Key Metrics Have to Say
- The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 08/08/2023
|
Zoetis' (ZTS) Q2 Earnings and Revenues Surpass Estimates
- Zoetis (ZTS) reports better-than-expected second-quarter 2023 results, beating both earnings and revenue estimates, primarily driven by the sales of its key dermatology products.
- 08/08/2023
|
Zoetis (ZTS) Beats Q2 Earnings and Revenue Estimates
- Zoetis (ZTS) came out with quarterly earnings of $1.41 per share, beating the Zacks Consensus Estimate of $1.32 per share. This compares to earnings of $1.20 per share a year ago.
- 08/08/2023
|
My Top 15 High Growth Dividend Stocks For August 2023
- The watchlist from July posted a gain of 5.36% last month, outperforming the SPDR S&P 500 Trust ETF and Vanguard's Dividend Appreciation ETF. The top 15 dividend growth stocks for August offer an average dividend yield of 1.58% and appear about 32% undervalued based on dividend yield theory. Since inception, September 2020, the watchlist is beating VIG by 5.24% and SPY by 4.53%.
- 08/05/2023
|
Rising Dividend Make Zoetis a Doggone Winner
- When Zoetis Inc. NYSE: ZTS reports second-quarter financials next week, the market will be expecting its best revenue growth in a year and a 9% jump in profits. If history repeats, the results will be even better.
- 08/03/2023
|
2 Healthcare Stocks That Could Make You Richer
- As a producer of medicines for animals, Zoetis benefits from increased spending on pets. Thanks to a strong product line, Eli Lilly briefly ranked as the biggest pharma company this year.
- 07/29/2023
|
Zoetis (ZTS) Moves 6.9% Higher: Will This Strength Last?
- Zoetis (ZTS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- 07/24/2023
|
Our Top 10 Picks For Dividend Growth Stocks - July 2023
- This monthly series of articles focuses on DGI stocks that are likely to provide a high rate of dividend growth rather than a high current yield. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. A balanced portfolio should have a mix of high-dividend growth stocks and high-yield dividend stocks, depending on the life stage. If you are in the accumulation phase and are several years away from retirement, high-growth dividend stocks would be more appropriate for long-term growth.
- 07/22/2023
|
Zoetis: My Dog Approves Of This Dividend Compounder
- Zoetis: My Dog Approves Of This Dividend Compounder
- 07/19/2023
|
2 Dividend Stocks That Doubled Their Payouts in 5 Years
- Zoetis and Mastercard don't offer high yields, but both aggressively raised their payouts in recent years. Both companies have modest payout ratios, suggesting more hikes could be on the way.
- 07/19/2023
|
JAZZ vs. ZTS: Which Stock Is the Better Value Option?
- Investors interested in stocks from the Medical - Drugs sector have probably already heard of Jazz Pharmaceuticals (JAZZ) and Zoetis (ZTS). But which of these two stocks offers value investors a better bang for their buck right now?
- 07/11/2023
|
Wall Street Analysts Believe Zoetis (ZTS) Could Rally 27.94%: Here's is How to Trade
- The average of price targets set by Wall Street analysts indicates a potential upside of 27.9% in Zoetis (ZTS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- 07/05/2023
|
My Top 15 High Growth Dividend Stocks For July 2023
- The watchlist from June posted a gain of 8.91% last month, outperforming the SPDR S&P 500 Trust ETF by 2.43% and Vanguard's Dividend Appreciation ETF by 2.41%. The top 15 dividend growth stocks for July offer an average dividend yield of 1.66% and appear about 34% undervalued based on dividend yield theory. Since inception, September 2020, the watchlist is beating VIG by 4.20% and SPY by 3.81%.
- 07/03/2023
|
Zoetis to Host Webcast and Conference Call on Second Quarter 2023 Financial Results
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Aug. 8, 2023. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review second quarter 2023 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-presentatio.
- 06/30/2023
|
Zoetis (ZTS) Just Reclaimed the 20-Day Moving Average
- After reaching an important support level, Zoetis (ZTS) could be a good stock pick from a technical perspective. ZTS surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend.
- 06/28/2023
|
There Are Plenty of Reasons to Like Zoetis
- Zoetis Inc. ( ZTS , Financial) is a leading animal health company with a diversified product portfolio of medicines and vaccines that aim to treat and protect livestock and companion animals.
- 06/27/2023
|
Zoetis: A Purrfect Addition To Your Portfolio
- Zoetis, a global leader in the animal health industry, has beaten the S&P 500 over the last five years and offers diverse growth opportunities. The company has a strong international presence, a commitment to innovation, and a focus on key growth areas such as dermatology, parasiticides, pain, diagnostics, and emerging markets. Despite a high valuation and significant debt, Zoetis is a high-quality business that could reward patient, long-term investors.
- 06/22/2023
|
History Suggests This S&P 500 Dividend Stock Is Perfect to Buy and Hold Forever
- Zoetis has more than doubled the S&P 500's return over the past decade. The animal health company's return on invested capital has risen to over 18%.
- 06/21/2023
|
My Top 15 High Growth Dividend Stocks For June 2023
- I present my top 15 high-growth dividend stocks to consider during the month of June. The watchlist underperformed VIG in May, but continues to outpace the ETF year-to-date and since inception. Five new stocks have been added to the watchlist for June: Intuit, Mastercard, Microchip Technology Inc., Sirius XM Holdings, and Skyworks Solutions.
- 06/03/2023
|
Zoetis' Dividend Growth: Small Yield, Big Returns
- The article discusses Zoetis, a low-yielding dividend stock with high dividend growth potential. Zoetis is the world's leading producer of medicine and vaccinations for pets and livestock, with a global footprint of over 100 markets and more than 70 years of experience.
- 05/10/2023
|
Zoetis (ZTS) Q1 Earnings Top Estimates
- Zoetis (ZTS) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.32 per share a year ago.
- 05/04/2023
|
Zoetis Tumbles As Spot's Drugmaker Reports Mixed Earnings, Though Keeps Outlook
- Animal health behemoth Zoetis reported a mixed first quarter but kept its full-year outlook. Still, ZTS stock tumbled early Thursday.
- 05/04/2023
|
Zoetis Stock Falls Amid Mixed Earnings Report
- The animal health provider maintained its guidance for full year 2023 after first quarter earnings beat expectations.
- 05/04/2023
|
My Top 15 High-Growth Dividend Stocks For May 2023
- I present my top 15 high-growth dividend stocks to consider during the month of May. The watchlist posted a gain of 0.41% in April, trailing both VIG and SPY.
- 05/01/2023
|
Zoetis Announces Date for 2023 Investor Day
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #Fortune500--Zoetis Inc. (NYSE:ZTS) will host an Investor Day on Thursday, May 25, 2023, at the New York Stock Exchange featuring Kristin Peck, Chief Executive Officer; Wetteny Joseph, Chief Financial Officer; Robert Polzer, Ph.D., President of Research and Development; and other members of the Zoetis executive team. Zoetis will provide an update on the company's strategy to deliver long-term profitable growth and value for shareholders, followed by a Q&A session. The.
- 05/01/2023
|
5 Women-Led Businesses Absolutely Crushing the Stock Market Right Now
- Women hold a tiny fraction of the CEO jobs at America's biggest companies. That number is steadily increasing.
- 04/30/2023
|
Why These 2 Vet Med Stocks Are Surging
- Nearly 87 million households -- over two-thirds of the total -- own at least one pet. Spending on pet healthcare could nearly double by 2030 to $112 billion.
- 04/28/2023
|
3 Pet Stocks That Could Purr in 2023 and Beyond
- Animal-loving investors may be interested in exploring opportunities in the pet industry. While there are altruistic reasons for supporting companies that focus on the well-being of our furry friends, pet stocks have also seen impressive growth over the past decade, which was accelerated by the pandemic.
- 04/24/2023
|
ALPMY or ZTS: Which Is the Better Value Stock Right Now?
- Investors interested in Medical - Drugs stocks are likely familiar with Astellas Pharma Inc. (ALPMY) and Zoetis (ZTS). But which of these two stocks presents investors with the better value opportunity right now?
- 04/18/2023
|
2 Pet Stocks Poised to Benefit From Industry Growth
- During the pandemic lockdowns, adopting pets became popular, resulting in a whopping 5 million more pets being added to households in the U.S. Morgan Stanley predicts that the overall spending in the pet industry will grow at a compounded annual growth rate of 8% and will be worth $277 billion by 2030, reaching $1,320 per pet per household in 2025 and $1,897 by 2030. Thus, let's take a look at two industry-leading stocks poised to benefit from this trend.
- 04/12/2023
|
Zoetis: Great Business, Fair Price
- Peter Drucker, who is widely considered the father of modern management, famously said that a business only has two basic functions and Zoetis is thriving on both these fronts. Numbers continue to trend in the right direction despite looming threats on the horizon.
- 04/06/2023
|
My Top 15 High-Growth Dividend Stocks For April 2023
- I present my top 15 high-growth dividend stocks to consider during the month of April. The watchlist posted a gain of 2.02% in March, finishing ahead of VIG but trailing SPY.
- 04/03/2023
|
3 Healthcare Stocks to Watch As the Industry Evolves
- In 2022, healthcare stocks surpassed the S&P 500. But in 2023, they are not doing so well.
- 03/31/2023
|
Analysts Agree Now's The Time To Buy These 10 Promising Stocks
- Finding S&P 500 stocks that analysts agree on is rare. So when you see nearly unanimous agreement on some, that's quite a statement.
- 03/28/2023
|
3 Awesome Dividend Growth Stocks To Buy During A Bear Market
- Markets are in turmoil. Hence, in this article, we start with a discussion of the risks facing investors and why I believe in attractive buying opportunities this year. While I understand that investors often opt for higher-yielding investments, I will explain why investments in low-yielding dividend-growth stocks come with benefits.
- 03/14/2023
|
My Top 15 High-Growth Dividend Stocks For March 2023
- I present my top 15 high-growth dividend stocks to consider during the month of March. The watchlist posted loss of 2.94% in February, finishing behind VIG and SPY on the month.
- 03/02/2023
|
COLL vs. ZTS: Which Stock Should Value Investors Buy Now?
- COLL vs. ZTS: Which Stock Is the Better Value Option?
- 03/01/2023
|
Final Trades: Arista Networks, Zoetis, Alaska Air & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 02/24/2023
|
Why Zoetis Stock Shot Almost 9% Higher This Week
- Robust net-income growth and better-than-expected guidance brought the bulls back to the animal health specialist.
- 02/17/2023
|
Zoetis, Pet-Med Specialist, Double-Digit Earnings Growth Ahead
- The stock is up 7.99 in the past week, after topping fourth-quarter views in its February 14 report. It also guided toward robust sales this year.
- 02/16/2023
|
Final Trades: Zoetis, Citigroup & Nvidia
- The "Halftime Report" traders give their top picks to watch for the second half.
- 02/14/2023
|
Zoetis' (ZTS) Q4 Earnings in Line With Estimates, Revenues Beat
- Zoetis' (ZTS) fourth-quarter 2022 earnings per share was at par with the Zacks Consensus Estimate, while revenues beat the same. The company provides its financial guidance for 2023.
- 02/14/2023
|
Zoetis Inc. (ZTS) Q4 2022 Earnings Call Transcript
- Zoetis Inc. (NYSE:ZTS ) Q4 2022 Earnings Conference Call February 14, 2023 8:30 AM ET Company Participants Steve Frank - Vice President, Investor Relations Kristin Peck - Chief Executive Officer Wetteny Joseph - Chief Financial Officer Conference Call Participants Michael Ryskin - Bank of America Jon Block - Stifel Erin Wright - Morgan Stanley Louise Chen - Cantor Nathan Rich - Goldman Sachs David Westenberg - Piper Sandler Chris Schott - JPMorgan Brandon Vazquez - William Blair Elliot Wilbur - Raymond James Operator Welcome to the Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast for Zoetis. Hosting the call today is Steve Frank, Vice President of Investor Relations for Zoetis.
- 02/14/2023
|
Zoetis (ZTS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
- The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended December 2022, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 02/14/2023
|
Zoetis (ZTS) Matches Q4 Earnings Estimates
- Zoetis (ZTS) delivered earnings and revenue surprises of 0% and 1.72%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/14/2023
|
Zoetis Snags A Quarterly Sales Beat And Issues A Strong 2023 Outlook
- Animal health giant Zoetis beat fourth-quarter sales expectations Tuesday and issued a strong 2023 outlook, leading ZTS stock to pop. The post Zoetis Snags A Quarterly Sales Beat And Issues A Strong 2023 Outlook appeared first on Investor's Business Daily.
- 02/14/2023
|
COLL or ZTS: Which Is the Better Value Stock Right Now?
- COLL vs. ZTS: Which Stock Is the Better Value Option?
- 02/13/2023
|
3 Stocks to Avoid This Week
- These investments seem pretty vulnerable right now.
- 02/13/2023
|
My Top 15 High-Growth Dividend Stocks For February 2023
- I present my top 15 high-growth dividend stocks to consider during the month of February. The watchlist posted a gain of 9.44% in January and starts the new year on a positive note.
- 02/02/2023
|
4 Top Stocks With High Dividend Growth to Buy in 2023 and Hold Forever
- These businesses offer powerful passive income potential, growing their dividends between 178% and 481% over the last five years.
- 01/28/2023
|
UTHR vs. ZTS: Which Stock Is the Better Value Option?
- UTHR vs. ZTS: Which Stock Is the Better Value Option?
- 01/27/2023
|
3 Reasons to Buy Zoetis, and 1 Reason to Sell
- This stock is a proven long-term play, but it's struggling lately.
- 01/17/2023
|
Top 10 Dividend Growth Stocks For January 2023
- This article will focus on DGI stocks that are likely to provide a high rate of dividend growth rather than a high current yield. High-growth dividend stocks are particularly suited for folks who are in the accumulation phase and are several years away from retirement.
- 01/17/2023
|
3 Upcoming Dividend Increases
- All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 9.6% and a median increase of 11.9%.
- 01/12/2023
|
Why Zoetis Stock Lost 40% in 2022
- Sluggish growth and multiple headwinds weighed on the stock.
- 01/11/2023
|
Final Trades: Abbott Labs, SL Green, Zoetis & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 01/11/2023
|
COLL vs. ZTS: Which Stock Is the Better Value Option?
- COLL vs. ZTS: Which Stock Is the Better Value Option?
- 01/11/2023
|
Zoetis CEO Kristin Peck on veterinary workforce challenges and recession resilience of pet industry
- Kristin Peck, CEO of Zoetis, joins 'The Exchange' to discuss the pandemic pet boom, demographic shifts among pet owners, and the labor capacity issues associated with veterinary services.
- 01/10/2023
|
It's A Great Time To Buy Zoetis Shares
- Zoetis has a very strong competitive moat resulting from its patents, scale, and respected brands. It has been delivering above-market growth for many years, and its profit margins have been on an upward trend.
- 01/09/2023
|
The 7 Most Undervalued Value Stocks to Buy Now
- Investors are entering a new era that could very well be dominated by value investing for quite some time. As a result, investors should look for undervalued value stocks to buy now.
- 01/08/2023
|
Is Zoetis Stock a Buy?
- Zoetis' business is generally stable and very consistent -- but the same can't be said for its struggling stock.
- 01/05/2023
|
Mutual Funds Are Investing In 'Survivors' For 2023
- Stock picking is an art in a tough market. Learn which companies mutual fund managers believe can grow during economic uncertainty.
- 12/30/2022
|
Tesla is not alone: 18 (and a half) other big stocks are headed for their worst year on record
- In the worst year for stocks since the Great Recession, several big names are headed for their worst year on record with just one trading day left in 2022.
- 12/29/2022
|
7 Long-Term Stocks to Put on Your Buy List in 2023
- 2022 wasn't a banner year for most investors. Major American equity markets fell into bear market territory.
- 12/29/2022
|
ASRT vs. ZTS: Which Stock Is the Better Value Option?
- ASRT vs. ZTS: Which Stock Is the Better Value Option?
- 12/26/2022
|
2 Beaten-Down Industry-Leading Stocks to Buy and Hold
- These companies' recent stock market performances don't tell the whole story.
- 12/26/2022
|
Zoetis CEO on egg price increases
- Cramer spoke with Zoetis CEO Kristin Peck on Thursday.
- 12/22/2022
|
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2022 Financial Results
- PARSIPPANY, N.J.--( BUSINESS WIRE )--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Feb. 14, 2023. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review fourth quarter and full year 2022 financial results and respond to questions from financial analysts during the call.
- 12/22/2022
|
3 Beaten-Down Stocks That Could Explode Higher in 2023
- These stocks could have significant upside opportunities ahead.
- 12/17/2022
|
JPMorgan's bullish call on biopharma
- The "Halftime Report" traders debate the biggest analyst calls of the day.
- 12/16/2022
|
7 Best Bargain Stocks to Buy in 2023
- 2022 was a year of soaring consumer prices and falling stock prices. I'm sure most investors will be happy to put it behind them, perhaps after some tax-loss harvesting.
- 12/13/2022
|
11% Of S&P 500 Stocks Suffer Their Worst Year Ever
- Tesla isn't the only stock that's struggling in 2022. Nearly 60 S&P 500 stocks — or about 11% — are having their worst year ever.
- 11/28/2022
|
ASRT vs. ZTS: Which Stock Is the Better Value Option?
- ASRT vs. ZTS: Which Stock Is the Better Value Option?
- 11/23/2022
|
Families are adopting, spending more on pets amid pandemic: Zoetis CEO
- Shelters have seen pet adoptions increase 15% year over year. As Americans spend more time at home with their companions, it has led to more spending on pet care, animal pharmaceuticals provider Zoetis CEO Kristin Peck explained.
- 11/19/2022
|
Pet adoption theme will continue, says petcare company Zoetis' CEO
- Pet care company Zoetis beat on the top and bottom lines after reporting earnings this morning. The company is seeing strong momentum for 2021, despite pandemic uncertainty.
- 11/19/2022
|
ASRT vs. ZTS: Which Stock Should Value Investors Buy Now?
- ASRT vs. ZTS: Which Stock Is the Better Value Option?
- 11/07/2022
|
2 Pet Medicine Stocks That Make Great Long-Term Investments
- Two of the biggest names in animal care continue to grow.
- 11/07/2022
|
Why Zoetis Stock Was Falling Today
- The animal healthcare company missed estimates in its third-quarter earnings report.
- 11/03/2022
|
Demand for animal medicine remains fundamentally strong, says Zoetis CEO Kristin Peck
- Zoetis CEO Kristin Peck joins 'Closing Bell' to discuss Zoetis stocks dropping after a worse than expected earnings report, the supply constraints that has been adding pressure to key growth drivers, and the demand outlook for 2023.
- 11/03/2022
|
Zoetis' (ZTS) Lags Q3 Earnings Estimates, Lowers 2022 Guidance
- Zoetis' (ZTS) earnings miss estimates in third-quarter 2022. Revenues, though up, also miss estimates due to the supply constraints in the international market.
- 11/03/2022
|
Zoetis (ZTS) Q3 Earnings and Revenues Miss Estimates
- Zoetis (ZTS) delivered earnings and revenue surprises of -2.42% and 3.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/03/2022
|
Zoetis (ZTS) to Report Q3 Earnings: Is a Beat in Store?
- Zoetis (ZTS) is anticipated to report positive earnings and revenues for third-quarter 2022. It will also provide an update on its pipeline on the earnings call.
- 10/31/2022
|
JAZZ or ZTS: Which Is the Better Value Stock Right Now?
- JAZZ vs. ZTS: Which Stock Is the Better Value Option?
- 10/20/2022
|
Daily Dividend Report: McDonald's, Qualcomm, Agree Realty, Zoetis, NextEra Energy
- Daily Dividend Report: McDonald's, Qualcomm, Agree Realty, Zoetis, NextEra Energy
- 10/14/2022
|
A Rising Dollar May Mean Lower Zoetis Shares
- While investors may be tempted to buy into Zoetis given its weakness this year, there is likely further downside. The livestock business has seen revenue decline due to generics competition and favorable tailwinds in companion animals may be fading.
- 10/07/2022
|
Zoetis to Host Webcast and Conference Call on Third Quarter 2022 Financial Results
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #fortune500--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Nov. 3, 2022. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review third quarter 2022 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-presentatio
- 09/29/2022
|
2 Stocks to Buy Near Their 52-Week Lows
- Let's not forget one of the first rules of investing: Buy low.
- 09/24/2022
|
TAK vs. ZTS: Which Stock Should Value Investors Buy Now?
- TAK vs. ZTS: Which Stock Is the Better Value Option?
- 09/21/2022
|
Zoetis to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #Fortune500--Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 2:05 p.m. ET. Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events
- 09/09/2022
|
TAK or ZTS: Which Is the Better Value Stock Right Now?
- TAK vs. ZTS: Which Stock Is the Better Value Option?
- 09/05/2022
|
5 Pet Care Stocks Gurus Love
- Despite inflationary pressures that are increasing the price of goods across the board, consumers are still pampering their pets when it comes to food.
- 09/02/2022
|
3 Dividend Stocks That Have Made Monster-Size Rate Hikes This Year
- These stocks have all raised their dividend payments by at least 30% within the past 12 months.
- 08/25/2022
|
Frank Sands' Top New Tech Buys
- Sands Capital Management recently disclosed its 13F portfolio updates for the second quarter of 2022, which ended on June 30.
- 08/22/2022
|
TAK vs. ZTS: Which Stock Is the Better Value Option?
- TAK vs. ZTS: Which Stock Is the Better Value Option?
- 08/19/2022
|
Zoetis: Strong Q2 Underlying Growth But Hit By Strong U.S. Dollar
- Zoetis released Q2 results last Thursday, and shares have fallen another 4% since, to 31% below their December 2021 peak. Net Income was flat year-on-year in Q2, but primarily due to currency. Operationally, revenues grew 8% and Net Income grew 9%.
- 08/12/2022
|
The 'recession-resistant' market that may have investors rolling over
- Zoetis CFO Wetteny Joseph joins Yahoo Finance Live to discuss earnings and the market for pet health and spending.
- 08/05/2022
|
These Are The Ten Biggest Companies With Over 90% Institutional Ownership
- Institutional investors are big investors that generally buy shares on behalf of their clients or members.
- 08/04/2022
|
Trends in pet care are driven by younger people getting pets, says Zoetis CEO
- Kristin Peck, Zoetis CEO, joins 'Closing Bell' to discuss the company's quarterly earnings results, the market reaction and how inflation is impacting Zoetis.
- 08/04/2022
|
Zoetis' (ZTS) Q2 Earnings Miss Estimates, Revenues Up
- Zoetis' (ZTS) earnings miss estimates in second-quarter 2022. The revenues beat estimates owing to the strong uptake of the company's companion animal portfolio products.
- 08/04/2022
|
Zoetis Trims Full-Year Outlook Following Mixed Second Quarter
- Zoetis narrowly missed quarterly earnings estimates, though sales came in above forecasts. But Zoetis trimmed its outlook and ZTS stock fell.
- 08/04/2022
|
TAK vs. ZTS: Which Stock Should Value Investors Buy Now?
- TAK vs. ZTS: Which Stock Is the Better Value Option?
- 08/03/2022
|
Zoetis: Lovable Company With Vision
- Zoetis is a global leader of Animal Healthcare products. They have a diverse and durable portfolio consisting of medicines, vaccines, diagnostics, and genetics.
- 07/20/2022
|
ASRT vs. ZTS: Which Stock Should Value Investors Buy Now?
- ASRT vs. ZTS: Which Stock Is the Better Value Option?
- 07/18/2022
|
Why Zoetis (ZTS) Could Beat Earnings Estimates Again
- Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/14/2022
|
Final Trades: Delta, Zoetis & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 07/08/2022
|
3 Best Farming Stocks to Buy
- While prices at the grocer continue to soar, today investors have a chance to buy three of the market's best farming stocks on the cheap! The post 3 Best Farming Stocks to Buy appeared first on InvestorPlace.
- 07/08/2022
|
Zoetis to Host Webcast and Conference Call on Second Quarter 2022 Financial Results
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #earnings--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Aug. 4, 2022. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review second quarter 2022 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-presentati
- 06/30/2022
|
ASRT or ZTS: Which Is the Better Value Stock Right Now?
- ASRT vs. ZTS: Which Stock Is the Better Value Option?
- 06/29/2022
|
ASRT vs. ZTS: Which Stock Is the Better Value Option?
- ASRT vs. ZTS: Which Stock Is the Better Value Option?
- 06/13/2022
|
Zoetis to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference
- PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference on Monday, June 13, 2022. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 4:20 p.m. ET (1:20 p.m. PT). Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.co
- 06/10/2022
|
Mosaic Company Or Zoetis Inc.: Which Is A Buy In The Array Of Agribstocks
- The Mosaic Company, through its subsidiaries, produces and markets concentrated phosphate and potash crop nutrients in North America and internationally. It owns and operates mines, which produce concentrated phosphate crop. Institutions hold 90% of shares, insiders less than 0.1%, and may ignore dividends yielding 1% yearly. Prior price range forecasts at today's reward~risk ratios net-realized 42% CAGRs.
- 06/06/2022
|
Final Trades: Zoetis, Costco, Disney & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 05/27/2022
|
ASRT vs. ZTS: Which Stock Should Value Investors Buy Now?
- ASRT vs. ZTS: Which Stock Is the Better Value Option?
- 05/26/2022
|
Zoetis: Animal Health Leader Now Cheapest Since April 2021
- Zoetis: Animal Health Leader Now Cheapest Since April 2021
- 05/20/2022
|
Vanguard Health Care Fund's Top 5 Trades in the 1st Quarter
- The Vanguard Health Care Fund (Trades, Portfolio) recently disclosed its first quarter 2022 portfolio, revealing that its top five trades for the quarter included a new position in Zoetis Inc. ( ZTS , Financial), a boost to its holding in Daiichi Sankyo Co. Ltd. ( TSE:4568 , Financial), the closure of its position in Elanco Animal Health Inc. ( ELAN , Financial) and reductions to its holdings in Bristol-Myers Squibb Co. ( BMY , Financial) and Anthem Inc. ( ANTM , Financial).
- 05/09/2022
|
7 Defensive Dividend Healthcare Stocks to Buy Now
- As market conditions remain rocky, adding high-quality healthcare stocks to your portfolio may be a great way to play defense. The post 7 Defensive Dividend Healthcare Stocks to Buy Now appeared first on InvestorPlace.
- 05/06/2022
|
Zoetis Inc. (ZTS) CEO Kristin Peck on Q1 2022 Results - Earnings Call Transcript
- Zoetis Inc. (NYSE:ZTS ) Q1 2022 Earnings Conference Call May 5, 2022 8:30 AM ET Company Participants Steve Frank - VP, IR Kristin Peck - CEO Wetteny Joseph - CFO Conference Call Participants Erin Wright - Morgan Stanley Christine Rains - William Blair Louise Chen - Cantor Nathan Rich - Goldman Sachs Michael Ryskin - Bank of America Jon Block - Stifel Balaji Prasad - Barclays Chris Schott - JPMorgan Steve Scala - Cowen Elliott Wilbur - Raymond James Operator Welcome to the First Quarter 2022 Financial Results Conference Call and Webcast for Zoetis. Hosting the call today is Steve Frank, Vice President of Investor Relations for Zoetis.
- 05/05/2022
|
Zoetis' (ZTS) Q1 Earnings and Revenues Surpass Estimates
- Zoetis' (ZTS) earnings and revenues trump estimates in the first quarter of 2022.
- 05/05/2022
|
Zoetis (ZTS) Tops Q1 Earnings and Revenue Estimates
- Zoetis (ZTS) delivered earnings and revenue surprises of 8.20% and 0.88%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/05/2022
|
Drug/Biotech Stocks Q1 Earnings Due on May 5: VRTX, ZTS & More
- Let's look at the five biotech/drug companies, slated to release quarterly results on May 5.
- 05/04/2022
|
Final Trades: Zoetis, Occidental, Paramount & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 05/02/2022
|
Is a Beat in Store for Zoetis (ZTS) This Earnings Season?
- Zoetis (ZTS) is set to report earnings and revenue figures and provide updates on its pipeline when it releases first-quarter 2022 results.
- 05/02/2022
|
Zoetis (ZTS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
- Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/28/2022
|
Why the Earnings Surprise Streak Could Continue for Zoetis (ZTS)
- Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 04/20/2022
|
Why You Might Want To Add Zoetis To Your Portfolio
- In an inflationary environment, you want to be in companies with strong pricing power such as Zoetis. The company is well managed and has been growing at a very decent pace, it pays a small dividend but earnings growth has been solid.
- 04/13/2022
|
COLL or ZTS: Which Is the Better Value Stock Right Now?
- COLL vs. ZTS: Which Stock Is the Better Value Option?
- 04/06/2022
|
COLL or ZTS: Which Is the Better Value Stock Right Now?
- COLL vs. ZTS: Which Stock Is the Better Value Option?
- 03/21/2022
|
Zoetis to Participate in the Barclays Global Healthcare Conference
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #Fortune500--Zoetis will participate in the Barclays Global Healthcare Conference on Thursday, March 17, 2022.
- 03/11/2022
|
Down 9% In A Month, Will Zoetis Stock Rebound?
- The stock price of Zoetis, an animal health company, has seen a 9% fall in a month, while it is down 6% in a week. The company reported upbeat Q4 results last month, with revenue of $2.0 billion and adjusted EPS of $1.00, beating the consensus estimates of $1.9 billion and $0.96, respectively.
- 03/10/2022
|
Librarian Capital's Monthly Top Buys And Price Moves - March 2022
- Librarian Capital's Monthly Top Buys And Price Moves - March 2022
- 03/03/2022
|
3 Beaten-Down Growth Stocks With More Than 50% Upside Potential
- The key to picking growth stocks right now is to look for companies whose earnings momentum and growth can withstand any market conditions. The post 3 Beaten-Down Growth Stocks With More Than 50% Upside Potential appeared first on InvestorPlace.
- 02/25/2022
|
Russia-Ukraine Tensions Escalate: 3 ETFs to Buy
- Russian aggression against Ukraine has sent commodities and gold higher
- 02/23/2022
|
Zoetis: Upgrade To Buy After 22% Fall From Peak And Strong Q4
- We upgrade our rating on Zoetis to Buy, after shares have fallen 22% from their peak, to below the level at our downgrade 7 months ago. Zoetis is a high-quality business capable of a 10%+ EPS CAGR long term. Its trailing P/E is now 41.2x, compared to 51.8x at our downgrade.
- 02/18/2022
|
People are spending more time and money on their pets, says Zoetis CEO Kristin Peck
- Zoetis CEO Kristin Peck joined 'Closing Bell' to discuss the company's 4th quarter sales and the strength of pet products.
- 02/16/2022
|
Zoetis Inc. (ZTS) CEO Kristin Peck on Q4 2021 Results - Earnings Call Transcript
- Zoetis Inc. (ZTS) CEO Kristin Peck on Q4 2021 Results - Earnings Call Transcript
- 02/15/2022
|
Zoetis tops earnings estimates and offers upbeat revenue guidance, shares up 1.5% premarket
- Animal health company Zoetis Inc.'s shares ZTS, -1.23% jumped 1.5% premarket Tuesday, after it beat estimates for the fourth quarter and offered upbeat revenue guidance for 2022. The company posted net income of $414 million, or 87 cents a share, for the quarter, up from $359 million, or 75 cents a share, in the year-earlier period.
- 02/15/2022
|
Top 5 Stocks to Buy on the Dip Despite Market Fluctuations
- We have narrowed our search to five U.S. corporate giants (market capital > $50 billion) that are currently trading on the dip. These are: TSLA, GM, FDX, MRVL and ZTS.
- 01/31/2022
|
2 Stocks That Could Turn $250,000 Into $1,000,000 By 2032
- Both of these companies are leaders in their respective industries.
- 01/23/2022
|
7 of the Top-Rated Pharmaceutical Stocks for Q1
- As the market begins to shift from high-growth, tech-fueled start-ups, one good long-term growth option is quality pharmaceutical stocks. The post 7 of the Top-Rated Pharmaceutical Stocks for Q1 appeared first on InvestorPlace.
- 01/18/2022
|
FDA Approves Zoetis' Solensia To Control Osteoarthritis Pain In Cats
- The FDA has approved Zoetis Inc's (NYSE: ZTS) Solensia (frunevetmab injection) to control the pain of osteoarthritis (OA) in cats, helping improve their mobility, comfort, and overall well-being. Solensia, prescribed as a once-monthly injection administered in the veterinary clinic, controls OA pain by targeting Nerve Growth Factor (NGF), a key driver in OA pain.
- 01/14/2022
|
Zoetis Has A Giant Upcoming Dividend Increase
- Zoetis Has A Giant Upcoming Dividend Increase
- 01/14/2022
|
Why Zoetis Stock Gained 47% in 2021
- The animal health company delivered strong results over the year.
- 01/12/2022
|
Zoetis CEO says the animal health company is stepping up its spending on consumer advertising
- Zoetis CEO Kristin Peck appeared on Tuesday's episode of "Mad Money," discussing the company's spending on direct-to-consumer advertising and efforts to maintain attractive prices for its products.
- 01/11/2022
|
Here's Why Zoetis (ZTS) is Poised for a Turnaround After Losing 8.8% in 4 Weeks
- Zoetis (ZTS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
- 01/10/2022
|
CORT vs. ZTS: Which Stock Is the Better Value Option?
- CORT vs. ZTS: Which Stock Is the Better Value Option?
- 01/05/2022
|
4 Top Stock Trades for Wednesday: AVGO, AMD, ARKK, ZTS
- Advanced Micro Devices, Broadcom, the ARKK ETF and Zoetis were our top stock trades for Wednesday. Now, let's take a look at the charts.
- 01/04/2022
|
Librarian Capital's Monthly Top Buys And Price Moves - January 2022
- Tobacco stocks remain strong buys after the defeat of the U.S. "nicotine tax" proposal and a reassuring update from British American Tobacco. In Payment, Mastercard and Visa each rebounded by more than 10%; U.S. holiday retail sales were strong and credit cards kept growing.
- 01/04/2022
|
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2021 Financial Results
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis will report Q4 and full year 2021 financial results on Tuesday, Feb. 15, 2022.
- 12/23/2021
|
CVS, Abbot, and Other Companies That Raised Their Dividends This Week
- Zoetis, Pentair, Johnson Controls International, and Abbott Laboratories were among the many companies that declared dividend increases this week.
- 12/12/2021
|
Zoetis, CVS Health, and Other Companies That Raised Their Dividends
- Zoetis, Pentair, Johnson Controls International, and Abbott Laboratories were among the many companies that declared dividend increases this week.
- 12/11/2021
|
Quieter Session Allows Indexes Digest Gains; EPAM, Cadence And Zoetis In Focus
- Quieter Session Allows Indexes Digest Gains; EPAM, Cadence And Zoetis In Focus Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market. Learn more.
- 12/08/2021
|
Zoetis Raises FY22 Dividend By 30%, Announces New Buyback Program Of $3.5B
- The board of directors of Zoetis Inc (NYSE: ZTS) has approved a $3.5 billion share repurchase program. The company added that the new share buyback, spanning across a multi-year period, could be canceled at any time.
- 12/08/2021
|
4 Large-Cap Stocks With High Returns on Equity
- When a company's return on equity (ROE) ratio is better than most of its competitors, it generally indicates that the company has been very efficient in generating profits. Thus, investors may want to consider the following stocks, as they are performing better than most of their peer group companies in terms of a higher ROE ratio.
- 11/28/2021
|
Animal care: People are ‘investing more in their pets' wellness,' Zoetis CFO says
- Zoetis CFO Wetteny Joseph joins Yahoo Finance's Emily McCormick to discuss Q3 earnings, global trends for pet health care, and COVID vaccines for animals. Don't Miss: Valley of Hype: The Culture That Built Elizabeth Holmes WATCH HERE: https://youtu.be/Sb179GLPNYE Watch the 2021 Berkshire Hathaway Annual Shareholders Meeting on YouTube: https://youtu.be/gx-OzwHpM9k
- 11/08/2021
|
There's a 'long tail' to Zoetis' growth, CEO believes
- Kristin Peck, Zoetis CEO, joins 'Closing Bell' to give a candid look at the company's Q3 earnings results and where Zoetis has seen steady, durable growth. Peck says they're on track for the company's best year and goes on to explain why she believes they'll continue to do well.
- 11/04/2021
|
Zoetis Inc. (ZTS) CEO Kristin Peck on Q3 2021 Results - Earnings Call Transcript
- Zoetis Inc. (ZTS) CEO Kristin Peck on Q3 2021 Results - Earnings Call Transcript
- 11/04/2021
|
Zoetis' (ZTS) Earnings and Revenues Surpass Estimates in Q3
- Zoetis' (ZTS) earnings and revenues beat estimates in the third quarter of 2021. The company raised its financial guidance for 2021.
- 11/04/2021
|
Zoetis (ZTS) Beats Q3 Earnings and Revenue Estimates
- Zoetis (ZTS) delivered earnings and revenue surprises of 13.64% and 2.74%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 11/04/2021
|
Is a Surprise Coming for Zoetis (ZTS) This Earnings Season?
- Zoetis (ZTS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 11/03/2021
|
Is a Beat in Store for Zoetis (ZTS) This Earnings Season?
- Zoetis (ZTS) is set to report earnings and revenues, and provide updates on its diversified product portfolio when it releases third-quarter 2021 results.
- 11/01/2021
|
4 Big Drug, Biotech Stocks Set to Beat Q3 Earnings Estimates
- Let us take a look at some drug/biotech stocks that are poised to beat on third-quarter earnings.
- 10/29/2021
|
ETO: A Solid Dividend Fund But Expensive
- ETO: A Solid Dividend Fund But Expensive
- 10/27/2021
|
Zoetis: Expensive But Precision Livestock Farming Division Could Be Game Changer
- Zoetis is the leader in pharmaceutical drugs, nutrition, and diagnostics for companion animals and livestock.
- 10/26/2021
|
Zoetis Announces Appointment of Robert J. Polzer, PhD, as President of Research & Development for World Leader in Animal Health
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #ResearchandDevelopment--Robert J. Polzer, PhD, will succeed current EVP and President of R&D at Zoetis, Dr. Catherine Knupp, DVM, MS.
- 10/18/2021
|
Zoetis to Host Webcast and Conference Call on Third Quarter 2021 Financial Results
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #earnings--Zoetis Inc. will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Nov. 4, 2021.
- 09/30/2021
|
Zoetis Named a “100 Best Company” and a “Best Company for Dads” by Seramount
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #Seramount100Best2021--Zoetis Named a “100 Best Company” and a “Best Company for Dads” by Seramount.
- 09/28/2021
|
COLL vs. ZTS: Which Stock Should Value Investors Buy Now?
- COLL vs. ZTS: Which Stock Is the Better Value Option?
- 09/20/2021
|
Zoetis to Participate in the Jefferies Virtual Pet Care Summit
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis to present at the Jefferies Virtual Pet Care Summit on Thursday, Sept. 16th.
- 09/13/2021
|
Final Trades: Bristol Myers, Marathon Petroleum, Zoetis & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 09/08/2021
|
7 Best Bear Market Stocks to Buy Now in Preparation for a Downturn
- These seven stocks to buy right now for a bear market are also generally strong in bull markets. Their resistance is the key element.
- 08/11/2021
|
Zoetis, Inc Among This Week's U.S. Large Caps Stocks
- Q.ai runs daily factor models to get the most up-to-date reading on stocks and ETFs. Today, our deep-learning algorithms have identified Zoetis, Inc among others.
- 08/10/2021
|
Zoetis CEO on Q2 results: “trends in companion animal are durable”
- Zoetis Inc. (NYSE: ZTS) reported its financial results for the second quarter on Thursday that beat Wall Street estimates. The stock was largely unbothered in after-hours trading despite raised guidance for the full year.
- 08/05/2021
|
Zoetis' (ZTS) Q2 Earnings and Revenues Surpass Estimates
- Zoetis (ZTS) earnings and revenues beat estimates in the second quarter of 2021. The company raised its financial guidance for 2021.
- 08/05/2021
|
Zoetis Inc. (ZTS) CEO Kristin Peck on Q2 2021 Results - Earnings Call Transcript
- Zoetis Inc. (ZTS) CEO Kristin Peck on Q2 2021 Results - Earnings Call Transcript
- 08/05/2021
|
Zoetis (ZTS) Surpasses Q2 Earnings and Revenue Estimates
- Zoetis (ZTS) delivered earnings and revenue surprises of 10.19% and 6.30%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 08/05/2021
|
Drug/Biotech Stocks Q2 Earnings Due on Aug 5: REGN, MRNA, ZTS, ILMN
- Let us take a look at what is in store for some of the drug/biotech stocks, which are scheduled to report on Aug 5.
- 08/04/2021
|
Why Earnings Season Could Be Great for Zoetis (ZTS)
- Zoetis (ZTS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 08/04/2021
|
Is a Beat in Store for Zoetis (ZTS) This Earnings Season?
- Zoetis (ZTS) will report earnings and revenues, and provide pipeline updates when it releases second-quarter 2021 results.
- 08/02/2021
|
4 Pharma/Biotech Stocks Poised to Beat on Earnings in Q2
- We take a look at a few pharma/biotech companies, which are poised to beat on earnings in the second quarter.
- 07/29/2021
|
CORT or ZTS: Which Is the Better Value Stock Right Now?
- CORT vs. ZTS: Which Stock Is the Better Value Option?
- 07/27/2021
|
Why Zoetis (ZTS) Could Beat Earnings Estimates Again
- Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/22/2021
|
Dividend Challenger Highlights: Week Of July 18
- Dividend Challenger Highlights: Week Of July 18
- 07/17/2021
|
Moderna Pops, Zoetis Drops, and Stocks Are Higher
- Futures on all three major U.S. stock exchanges were higher as investors assess better-than-expected news about retail sales.
- 07/16/2021
|
After A 10% Rise In A Month Zoetis Stock May Continue To See Higher Levels
- The stock price of Zoetis, an animal health company, has seen a 10% rise over the last twenty-one trading days, while it is up 40% over the last year. ZTS stock has benefited from an increased animal adoption in the U.S., which aided its sales for parasiticide products for companion animals.
- 07/08/2021
|
AMRX vs. ZTS: Which Stock Should Value Investors Buy Now?
- AMRX vs. ZTS: Which Stock Is the Better Value Option?
- 07/07/2021
|
Zoetis Donates COVID-19 Vaccines to Help Support the Health of Zoo Animals
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #DrivenToCare--Zoetis is donating more than 11,000 doses of its experimental COVID-19 vaccine for animals to nearly 70 zoos across the U.S.
- 07/02/2021
|
Pandemic Boosts Animal Health Spending: 4 Stocks to Buy
- Stocks like PetIQ (PETQ), IDEXX Laboratories (IDXX), Phibro Animal Health (PAHC) and Zoetis (ZTS) offering animal health products and services make great picks for long term.
- 06/29/2021
|
Zoetis: The Price To Pay For A Leader In Animal Health
- There are positive industry-wide tailwinds for Animal Health as a niche segment of the broader pharmaceuticals industry. Being a leader in Animal Health, ZTS is poised for long-term outperformance due to its innovative ability and strategic position.
- 06/27/2021
|
Does The Valuation Gap Between Merck Stock And Zoetis Make Sense?
- Zoetis stock has risen 2x from levels of $92 that it was at on March 23, 2020, when broader markets made a bottom, to levels of $184 now, while Merck's stock has underperformed and gained only 26% of its value. Looking at valuation, Merck stock trades at about 4x trailing revenues, compared.
- 06/21/2021
|
Overview Of Opportunities In Animal Companionship: A $200B Industry Growing At 6.1% Annually
- The physiological and psychological benefits that pets give us are meaningful. COVID has amplified our appreciation of this. Anticipating 6% annual growth until 2030 may be conservative, even across developed markets.
- 06/11/2021
|
Up 100% in a Year, Can This Animal Health Stock Keep Climbing?
- Not only has Heska stock doubled in a year, it has quintupled over the past five years, and it's a 20-bagger over the last decade. Why is this animal health stock flying so high?
- 06/09/2021
|
Zoetis to Participate in the William Blair 41st Annual Growth Stock Conference
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #WilliamBlair--Zoetis Inc. will participate in the William Blair 41st Annual Growth Stock Conference on Wednesday, June 2, 2021.
- 05/27/2021
|
Zoetis Earns the Best Place To Work Certification in Thailand for 2021
- BANGKOK--(BUSINESS WIRE)-- #BPTW4Thailand--Zoetis Thailand, an affiliate of the global animal health company dedicated to supporting customers and their businesses in ever better ways, has recently been recognized as one of the best places to work in Thailand for 2021. During the assessment, the company received outstanding scores across several aspects of their workplace going above and beyond the norm to create an enjoyable and meaningful work environment. In this very unusual year, we learned again that empl
- 05/24/2021
|
Zoetis Announces Results of Its Annual Meeting of Shareholders; Board Declares Third Quarter 2021 Dividend
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #annualmeeting--Zoetis announced the results of shareholder voting at its 2021 Annual Meeting of Shareholders and provided details on its third quarter 2021 dividend.
- 05/20/2021
|
Growth Stock Spotlight: Acquisition Pits CSOC as Fresh Option in Booming Petcare Market
- While the market has taken a beating over recent days, pullbacks are the mother's milk of effective investment strategies, and shrewd market participants will already have a growing shopping list on hand. With that in mind, one area that may deserve special attention and offer outsized potential ahead is the pet care space.
- 05/13/2021
|
Boost Your Future Income With These Fast Growing Dividends
- Fast growing dividends may have low initial yields but will grow rapidly over time.
- 05/12/2021
|
AMRX or ZTS: Which Is the Better Value Stock Right Now?
- AMRX vs. ZTS: Which Stock Is the Better Value Option?
- 05/10/2021
|
Zoetis (ZTS) Just Overtook the 20-Day Moving Average
- When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
- 05/10/2021
|
Zoetis: 3.7% Dip Despite Strong Q1 And Raised 2021 Outlook
- Zoetis stock fell 3.7% on Thursday despite stronger-than-expected Q1 results and a raised 2021 outlook, including Net Income growing 12-14%. In Q1, Zoetis revenues grew 21%, led by Companion Animals up 34% but with Livestock up 17% in International; Net Income grew 34%.
- 05/07/2021
|
Zoetis CEO discusses growth opportunities
- Kristin Peck, Zoetis CEO, joins 'Closing Bell' to discuss growth opportunities at the company.
- 05/06/2021
|
Zoetis Inc. (ZTS) CEO Kristin Peck on Q1 2021 Results - Earnings Call Transcript
- Zoetis Inc. (ZTS) CEO Kristin Peck on Q1 2021 Results - Earnings Call Transcript
- 05/06/2021
|
JAZZ vs. ZTS: Which Stock Is the Better Value Option?
- JAZZ vs. ZTS: Which Stock Is the Better Value Option?
- 04/22/2021
|
8 Retirement Stocks to Buy for Any Market Conditions
- 2020 shows that investors need to be prepared for anything. These eight retirement stocks can do precisely that.
- 04/06/2021
|
Steven Cohen Adopts Stake in Kindred Biosciences
- Point72 Asset Management leader Steven Cohen (Trades, Portfolio) disclosed a 9.31% stake in Kindred Biosciences Inc. (NASDAQ:KIN) earlier this week.
- 04/02/2021
|
USNA vs. ZTS: Which Stock Should Value Investors Buy Now?
- USNA vs. ZTS: Which Stock Is the Better Value Option?
- 03/17/2021
|
Why Zoetis Is the Pfizer of Animal Healthcare
- Zoetis has proven to investors that the pharmaceutical apple doesn't fall far from the tree.
- 03/16/2021
|
Zoetis: Multi-Year Compounder On Sale Again After 14% Correction
- We upgrade Zoetis to Buy after a 14% price decline, means this multi-year compounder once again offers a low-teens annualized return.
- 03/15/2021
|
Is Zoetis Still a Buy With Its Stock Near All-Time Highs?
- This leader in animal healthcare has shown strong financial performance through the years.
- 03/13/2021
|
Will Zoetis' Acquisition Spree Pay Off?
- The animal health leader continues to invest in its future.
- 03/13/2021
|
Zoetis Launches “Driven to Care” Sustainability Initiative and Long-Term Goals to Meet Commitments to Communities, Animals and the Planet
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #DrivenToCare--Zoetis today announced its long-term sustainability goals.
- 03/10/2021
|
Tuesday Morning Market Highlights
|
BofA Upgrades Zoetis Stock On Business Potential, Valuation
- Zoetis Inc (NYSE: ZTS) seems well-positioned in 2021 with the stock valuation offering an attractive entry point, according to BofA Securities. The Zoetis Analyst: Michael Ryskin upgraded the rating for Zoetis from Neutral to Buy, while maintaining a price target of $180.
- 03/08/2021
|
USNA or ZTS: Which Is the Better Value Stock Right Now?
- USNA vs. ZTS: Which Stock Is the Better Value Option?
- 03/01/2021
|
The Past Week's Notable Insider Buys: Agree Realty, Avis Budget, Zoetis And More
- Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Returning buyers and chief executives were among the insiders making purchases this week.
- 02/28/2021
|
2 Fundamentally Superior Stocks I Just Rang the Register On
- When it comes to stocks to buy, we are getting more selective, and that's a good thing. In fact, buying pressure in more selective stocks means they may have more profit potential going forward.
- 02/23/2021
|
Zoetis' Solensia Wins European Nod For Osteoarthritis Pain In Cats
- Animal health company Zoetis Inc (NYSE: ZTS) received the European Commission's marketing approval for Solensia (frunevetmab), an injectable monoclonal antibody for the alleviation of pain associated with osteoarthritis in cats. Solensia targets Nerve Growth Factor (NGF), a key player in osteoarthritis pain.
- 02/22/2021
|
Zoetis Receives European Commission Marketing Authorization for Solensia® (frunevetmab), a New Therapy for Feline Osteoarthritis Pain
- ZAVENTEM, Belgium--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis receives European Commission marketing authorization for Solensia® (frunevetmab), a new therapy for feline osteoarthritis pain.
- 02/22/2021
|
Pet adoption theme will continue, says petcare company Zoetis' CEO
- Pet care company Zoetis beat on the top and bottom lines after reporting earnings this morning. The company is seeing strong momentum for 2021, despite pandemic uncertainty.
- 02/16/2021
|
Zoetis says its revenue jumped 8% in the fiscal fourth quarter
- Zoetis Inc. (NYSE: ZTS) said on Tuesday that its revenue in the fiscal fourth quarter saw an 8% annualised growth to £1.29 billion. Its net income in Q4 stood at £258.21 million that translates to 53.94 pence per diluted share.
- 02/16/2021
|
Zoetis' (ZTS) CEO Kristin Peck on Q4 2020 Results - Earnings Call Transcript
- Zoetis' (ZTS) CEO Kristin Peck on Q4 2020 Results - Earnings Call Transcript
- 02/16/2021
|
Zoetis' (ZTS) Q4 Earnings and Revenues Surpass Estimates
- Zoetis (ZTS) beats both earnings and sales estimates in the fourth quarter of 2020.
- 02/16/2021
|
Zoetis Earnings Top, Guidance Strong; ZTS Stock Rises
- Zoetis earnings and sales were better than expected, while the animal drug giant guided high for 2021. ZTS stock rose early Tuesday.
- 02/16/2021
|
Is a Surprise Coming for Zoetis (ZTS) This Earnings Season?
- Zoetis (ZTS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 02/12/2021
|
Zoetis (ZTS) to Report Q4 Earnings: What's in the Cards?
- Zoetis (ZTS) will report earnings and revenues, and provide other pipeline updates when it releases fourth-quarter 2020 results.
- 02/11/2021
|
Zoetis Declares Second Quarter 2021 Dividend
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #dividend--Zoetis declares Q2'21 dividend.
- 02/10/2021
|
Earnings Preview: Zoetis (ZTS) Q4 Earnings Expected to Decline
- Zoetis (ZTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 02/09/2021
|
Forbes Names Zoetis One of America's Best Midsize Employers
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #Forbes--Zoetis has been named one of America's Best Midsize Employers by Forbes Magazine for the fifth time.
- 02/09/2021
|
GRFS vs. ZTS: Which Stock Is the Better Value Option?
- GRFS vs. ZTS: Which Stock Is the Better Value Option?
- 02/03/2021
|
Believe It or Not, There's Something to See With Zomedica
- There's a lot of hype around ZOM stock these days, but the name could prove to be a growth star among pet-related equities. The post Believe It or Not, There's Something to See With Zomedica appeared first on InvestorPlace.
- 01/28/2021
|
Zoetis Scores 100% on 2021 Corporate Equality Index
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #LGBTQ--Zoetis named a best place to work for LGBTQ equality.
- 01/28/2021
|
ZOM Stock: Why Zomedica Shares Are on the Move Again Today
- Zomedica shares are surging after the company updated investors on a warrant-redemption cash influx and news that its end-of-March product rollout is on track. Pet-related stocks are hot and ZOM may be on the verge of a significant breakout.
- 01/19/2021
|
9 Hot Stocks to Buy Now to Profit off Chinese Markets
- These are some of the top stocks to buy if you want to make a play on the growth and strength of the Chinese economy. The post 9 Hot Stocks to Buy Now to Profit off Chinese Markets appeared first on InvestorPlace.
- 01/15/2021
|
The 2021 Market Outlook And Some New Stock Picks - Ryan Detrick And Eddy Elfenbein Join Alpha Trader (Podcast Transcript)
- Welcome to Alpha Trader. We have a special double bill today in honor of wildcard weekend coming up on the show. Eddy Elfenbein of Crossing Wall Street giving us his top five new stocks for 2021. But first we are pleased to welcome back to the show, Ryan Detrick. He is Chief Market Strategist for LPL Financial. Ryan, welcome back to Alpha Trader.
- 01/14/2021
|
2 Dividend Increases To Consider
- Both stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. An average and median increase of 15.13%.
- 01/14/2021
|
Families are adopting, spending more on pets amid pandemic: Zoetis CEO
- Shelters have seen pet adoptions increase 15% year over year. As Americans spend more time at home with their companions, it has led to more spending on pet care, animal pharmaceuticals provider Zoetis CEO Kristin Peck explained.
- 01/13/2021
|
Growth In Pet Spending Is Off The Leash, Here Is How To Profit From It
- Rising pet ownership rates and a steadily increasing average household spending provide a powerful tailwind to this investment theme. Pet food, animal health, veterinary equipment, and specialized e-commerce are all fields prone to profit from the secular growth trend.
- 01/12/2021
|
GRFS or ZTS: Which Is the Better Value Stock Right Now?
- GRFS vs. ZTS: Which Stock Is the Better Value Option?
- 01/12/2021
|
The 2021 Market Outlook And Some New Stock Picks - Ryan Detrick And Eddy Elfenbein Join Alpha Trader
- This week's Alpha Trader podcast features hosts Aaron Task and Stephen Alpher speaking with LPL Financial's Ryan Detrick and Eddy Elfenbein, editor of the Crossing Wall Street blog and portfolio manager of the AdvisorShares Focused Equity ETF (CWS).
- 01/12/2021
|
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2020 Financial Results
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis will report Q4 and full year 2020 financial results on Tuesday, Feb 16, 2021.
- 12/30/2020
|
8 Pet Stocks That Will Make You Purr
- Americans love their pets, and no pandemic, not even the novel coronavirus, will change that, bolstering these eight pet stocks. The post 8 Pet Stocks That Will Make You Purr appeared first on InvestorPlace.
- 12/23/2020
|
5 Rational Biotech Stocks to Buy
- These biotech stocks allow you to profit off the innovations that are giving us longer, healthier lives through the companies that make them. The post 5 Rational Biotech Stocks to Buy appeared first on InvestorPlace.
- 12/22/2020
|
7 Healthcare Stocks to Buy With the Sector Under Scrutiny
- True, there are political risks in the industry. But there are also lots of growth opportunities for investors in healthcare stocks.
- 12/21/2020
|
Zoetis to Participate in the 39th Annual J.P. Morgan Healthcare Conference
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #JPM2021--Zoetis to present at the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021.
- 12/18/2020
|
Strong Fundamentals In The Animal Health Industry Will Drive Zoetis Shares To $200 And Beyond
- ZTS is the leader in the animal healthcare space, providing a multitude of products/services to customers. The company continues to have impressive earnings, even during the COVID pandemic and the management team is top tier.
- 12/11/2020
|
Zoetis Declares First Quarter 2021 Dividend; Board Approves 25% Payment Increase
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis declares Q1'21 dividend: Board approves 25% increase.
- 12/09/2020
|
Zoetis Appoints Tonie Leatherberry to Its Board of Directors
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis appoints Antoinette (Tonie) Leatherberry to its Board of Directors.
- 12/08/2020
|
Zoetis (ZTS) Down 7.6% Since Last Earnings Report: Can It Rebound?
- Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock?
- 12/05/2020
|
85 Million & Climbing: Why Pets = Profits for These 6 Companies
- More households own pets than have children, and they'll pay to keep their furry friends happy. Here are 6 big pet stocks.
- 12/03/2020
|
Zoetis Named One of the “Top 75 Companies for Executive Women” by Working Mother Media
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #DiversityandInclusion--For the third year in a row, Zoetis has been named one of the "Top 75 Companies for Executive Women" by Working Mother Media.
- 12/01/2020
|
7 Pharmaceutical Stocks to Buy for 2021 and Beyond
- Pharmaceutical stocks help make the world go round. Without them, common ailments would plague our lives.
- 11/17/2020
|
Zoetis Inc.'s (ZTS) CEO Kristin Peck on Q3 2020 Results - Earnings Call Transcript
- Zoetis Inc.'s (ZTS) CEO Kristin Peck on Q3 2020 Results - Earnings Call Transcript
- 11/06/2020
|
Pet adoption demand drives strong Q3 earnings for Zoetis
- Zoetis, the largest global animal health company, reported third quarter earnings results. The CEO of Zoetis Kristin Peck, says she sees long-term trends where people tend more to their pets even after the pandemic is over.
- 11/05/2020
|
Zoetis Earnings, Sales Top Expectations; Animal Health Giant Hikes Guidance
- Zoetis earnings beat views and the animal health giant hiked its guidance. Zoetis stock was little changed after spiking to a record high Wednesday.
- 11/05/2020
|
Zoetis to Participate in the Credit Suisse 2020 Virtual Healthcare Conference
- PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis to participate in the Credit Suisse Virtual Healthcare Conference on Nov. 10.
- 10/26/2020
|
